Drug
Cidofovir clinical trials
Also written Vistide.
- studies test it
- 29
- open now
- 0
- in phase 3
- 3
- first study started
- 1994
How studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 1994 | 1 |
| 1995 | 1 |
| 1996 | 1 |
| 1997 | 1 |
| 1999 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 10
- Phase 3
- 3
- Phase 4
- 2
- No phase
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 22
National Institute of Allergy and Infectious Diseases (NIAID) (6) · Gilead Sciences (6) · M.D. Anderson Cancer Center (3) · Gustave Roussy, Cancer Campus, Grand Paris (2) · Johns Hopkins Bloomberg School of Public Health (2) · Hospital Universitari Vall d'Hebron Research Institute (1) · University of Wisconsin, Madison (1) · Brugmann University Hospital (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Cidofovir is read from its arms, and is right about nine times in ten.
Testing it · 29
- Cidofovir Versus Best Supportive Care for Hemorrhagic CystitisActive, not recruitingPhase 2M.D. Anderson Cancer CenterNCT01295645Written as Cidofovir
- Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical CancersCompletedPhase 1Gustave Roussy, Cancer Campus, Grand ParisNCT02515877Written as Vistide
- Clinical Trial for Evaluating the Efficacy and Safety of Electrocoagulation vs Topic Sinecatechins vs Topic Cidofovir Within the Treatment to High-grade Anal Intraepithelial Neoplasia in HIV Homosexual MalesCompletedPhase 3Hospital Universitari Vall d'Hebron Research InstituteNCT04055142Written as cidofovir 1% topical ointment
- A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS PatientsCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00000945Written as Cidofovir
- A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) DiseaseWithdrawnPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000881Written as Cidofovir
- Cidofovir Instillation in Hematopoietic Stem Cell Transplant (HSCT) Recipients With Hemorrhagic CystitisWithdrawnNot applicableM.D. Anderson Cancer CenterNCT00956176Written as Cidofovir
- Use of Cidofovir for Recurrent Respiratory PapillomatosisCompletedPhase 4University of Wisconsin, MadisonNCT00205374Written as Cidofovir
- Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.WithdrawnPhase 2University of MinnesotaNCT02567149Written as Cidofovir
- Intravesical Cidofovir for Hemorrhagic CystitisCompletedPhase 1M.D. Anderson Cancer CenterNCT01816646Written as Cidofovir
- A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions.CompletedPhase 2Brugmann University HospitalNCT02976987Written as Cidofovir
- Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory PapillomatosisStatus unknownPhase 2Centro de Investigación en. Enfermedades Infecciosas, MexicoNCT02555800Written as Cidofovir
- A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ PatientsCompletedNot applicableFundacion SEIMC-GESIDANCT01946009Written as Cidofovir 1% cream's basis, 2gr, three times per week, during 4 weeks.
- Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)CompletedPhase 3Johns Hopkins Bloomberg School of Public HealthNCT00000143Written as Cidofovir intravenous
- Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the AnusCompletedPhase 2AIDS Malignancy ConsortiumNCT00550589Written as cidofovir
- Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)CompletedPhase 2/3Johns Hopkins Bloomberg School of Public HealthNCT00000142Written as Cidofovir
- Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV InfectionCompletedPhase 2National Cancer Institute (NCI)NCT00019240Written as cidofovir
- Cidofovir in Renal Transplant Recipients With BKVNTerminatedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00138424Written as Cidofovir
- HPMPC (Cidofovir) Peripheral CMV Retinitis Trial ProtocolCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00000799Written as Cidofovir
- Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV RetinitisCompletedPhase 4National Institute of Allergy and Infectious Diseases (NIAID)NCT00000894Written as Cidofovir
- Safety and Tolerability of Cidofovir Gel Applied on Cervix Squamous LesionsCompletedPhase 1Mithra PharmaceuticalsNCT00989443Written as Cidofovir gel
See all 29 studies that test Cidofovir →
As the comparator · 2 — what is tested is compared with Cidofovir
- A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCTRecruitingPhase 3SymBio PharmaceuticalsNCT07387367Written as cidofovir
- Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or CidofovirCompletedPhase 3ShireNCT02931539Written as Cidofovir
Codes
What other systems call Cidofovir · ClinicalTrials.gg INT006714
- MeSH (NLM) D000077404CidofovirConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) JIL713Q00NCIDOFOVIRConfirmed FDA, NLM, Wikidata
- RxNorm 83171Confirmed FDA, Wikidata
- Wikidata Q27126748cidofovir dihydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1600CidofovirConfirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077404 | Cidofovir | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | JIL713Q00N | CIDOFOVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 83171 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27126748 | cidofovir dihydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1600 | Cidofovir | Confirmed FDA, Wikidata |
Also registered as cidofovir anhydrous (UNII 768M1V522C · RxNorm 1546007) and cidofovir sodium (UNII M83JB37U61).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.